CVSA (Covista Inc.) Stock Analysis - News

Covista Inc. (CVSA) is a publicly traded the market company. As of May 21, 2026, CVSA trades at $126.01 with a market cap of $4.35B and a P/E ratio of 0.00. CVSA moved -0.08% today. Year to date, CVSA is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $94.11 to $133.74. Analyst consensus is strong buy with an average price target of $156.25. Rallies surfaces CVSA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What changed in CVSA news today?

Covista Unveils Canvas-Integrated AI Classroom, Sees 3,400 Enrollments in First Week: Covista is developing an AI-powered classroom integrated in Canvas, offering precision personalized learning across five institutions and piloting later this year. The healthcare-specific AI credentials launched in October attracted over 3,400 enrollments within the first week and now extend to students, alumni and professionals across nursing, medicine and additional disciplines.

CVSA Key Metrics

Key financial metrics for CVSA
MetricValue
Price$126.01
Market Cap$4.35B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$133.74
52-Week Low$94.11
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest CVSA News

Recent CVSA Insider Trades

  • Phelan Robert J. sold 10.00K (~$1.26M) on May 8, 2026.
  • BECK DOUGLAS G. sold 9.62K (~$1.22M) on May 8, 2026.
  • Cox Karen Sue sold 2.00K (~$249.00K) on May 8, 2026.

CVSA Analyst Consensus

4 analysts cover CVSA: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $156.25.

Common questions about CVSA

What changed in CVSA news today?
Covista Unveils Canvas-Integrated AI Classroom, Sees 3,400 Enrollments in First Week: Covista is developing an AI-powered classroom integrated in Canvas, offering precision personalized learning across five institutions and piloting later this year. The healthcare-specific AI credentials launched in October attracted over 3,400 enrollments within the first week and now extend to students, alumni and professionals across nursing, medicine and additional disciplines.
Does Rallies summarize CVSA news?
Yes. Rallies summarizes CVSA news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is CVSA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CVSA. It does not provide personalized investment advice.
CVSA

CVSA